4//SEC Filing
Payne Fletcher 4
Accession 0001567619-23-001162
CIK 0000882361other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:57 PM ET
Size
7.9 KB
Accession
0001567619-23-001162
Insider Transaction Report
Form 4
Payne Fletcher
SR VP & Chief Fin. Officer
Transactions
- Award
Common Shares
2023-01-19+100,000→ 100,000 total - Award
Employee Stock Option (Right to Buy)
2023-01-19+200,000→ 200,000 totalExercise: $0.66Exp: 2033-01-19→ Common Shares (200,000 underlying)
Holdings
- 10,000(indirect: By Trust)
Common Shares
Footnotes (1)
- [F1]Fifty percent (50%) of the options vest on January 19, 2024; the remaining fifty percent (50%) vest as follows: One-third (1/3) on January 19, 2025; one-third (1/3) on January 19, 2026; and one-third (1/3) on January 19, 2027.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001650476
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 7:57 PM ET
- Size
- 7.9 KB